🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of next-day British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could result in users administering products of unknown origin.

Some professionals said the popularity for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the British medical regulations.

Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Removal

According to the social media company, the platform has taken down violative material and prohibited associated keywords and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Operations

Investigations also found groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.

After minutes of joining one group, a vendor shared contact information, where the majority of transactions take place. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.

Product Information and Costs

Inside these communities, messages show dark colored packages with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to possibly significant medical dangers”.